Behavioral Health Clinical Policies

Behavioral Clinical Policies are criteria that stem from the evaluation of new behavioral health services or treatments, or new applications of existing services or treatments. The Behavioral Clinical Policies are used to make determinations for those services or treatments determined to be Experimental, Investigational, Proven or Unproven by the Optum Clinical Technology Assessment Committee.  

• Complementary and Alternative Medicine (CAM) Treatments
• Computer Based Treatment for Cognitive Behavioral Therapy (CBTCBT)
• Applied Behavior Analysis for Autism Spectrum Disorders - See Supplemental Clinical Criteria
• Neurofeedback
• Transcranial Magnetic Stimulation
• Wilderness Therapy
• California Health Plan Commercial – DMHC-regulated Transcranial Magnetic Stimulation, effective 07/01/2025
  • Canadian Journal of Psychiatry – September 2016 
  • Canadian Journal of Psychiatry – 2023 Update on Clinical Guidelines
• For Medicare Transcranial Magnetic Stimulation clinical criteria, please see click here: Transcranial Magnetic Stimulation
• Review Ohio State-Specific Medicaid Supplemental Clinical Criteria here